Your browser doesn't support javascript.
loading
Effect of neoadjuvant chemoradiotherapy on p53 and SOX2 protein expression in esophageal adenocarcinoma.
Suzuki, Lucia; Nieboer, Daan; van Lanschot, Jan Jb; Spaander, Manon Cw; Looijenga, Leendert Hj; Biermann, Katharina.
Affiliation
  • Suzuki L; Department of Pathology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Nieboer D; Department of Public Health, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • van Lanschot JJ; Department of Surgery, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Spaander MC; Department of Gastroenterology & Hepatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Looijenga LH; Department of Pathology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Biermann K; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Biomark Med ; 14(9): 785-793, 2020 06.
Article in En | MEDLINE | ID: mdl-32677456

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Adenocarcinoma / Gene Expression Regulation, Neoplastic / Tumor Suppressor Protein p53 / SOXB1 Transcription Factors / Chemoradiotherapy Type of study: Diagnostic_studies / Prognostic_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: Biomark Med Journal subject: BIOQUIMICA / MEDICINA Year: 2020 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Adenocarcinoma / Gene Expression Regulation, Neoplastic / Tumor Suppressor Protein p53 / SOXB1 Transcription Factors / Chemoradiotherapy Type of study: Diagnostic_studies / Prognostic_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: Biomark Med Journal subject: BIOQUIMICA / MEDICINA Year: 2020 Document type: Article Affiliation country: Country of publication: